Celltex Therapeutics Corporation

Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company established in 2011. The company is committed to pioneering advancements in regenerative medicine using adult, autologous Mesenchymal Stem Cells (MSCs). With a focus on breakthroughs in utilizing adipose-derived MSCs, Celltex is dedicated to advancing the potential of this technology. The company's recent progress includes securing a substantial $34.06M Venture Round investment on 06 July 2012, signifying confidence and support from the investment community. This funding is indicative of the recognition and potential of Celltex's innovative approach in biotechnology. As of now, the company does not disclose the specific details of the last investment investors, but the attention it has received in the form of significant investments demonstrates the industry's interest and confidence in Celltex's vision and capabilities. With its focus on pioneering breakthroughs and advancements in regenerative medicine, Celltex Therapeutics Corporation is poised to be a significant player in the field of biotechnology, offering potential investment opportunities in a rapidly evolving and promising sector.